Knockdown of MVK does not lead to changes in NALP3 expression or activation
暂无分享,去创建一个
[1] S. Ghavami,et al. Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. , 2014, Biochimica et biophysica acta.
[2] M. Boes,et al. Defects in Mitochondrial Clearance Predispose Human Monocytes to Interleukin-1β Hypersecretion , 2013, The Journal of Biological Chemistry.
[3] L. Monasta,et al. Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis , 2013, International journal of molecular sciences.
[4] E. Piscianz,et al. Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line , 2013, Cell Death and Disease.
[5] I. Dixon,et al. Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts , 2012, Cell Death and Disease.
[6] J. Yagüe,et al. Clinical, Genetic, and Therapeutic Diversity in 2 Patients With Severe Mevalonate Kinase Deficiency , 2012, Pediatrics.
[7] E. Piscianz,et al. Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes , 2011, Apoptosis.
[8] Frans Voorbraak,et al. Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. , 2010, Methods.
[9] Richard A Flavell,et al. Innate instruction of adaptive immunity revisited: the inflammasome , 2009, EMBO molecular medicine.
[10] A. Moorman,et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data , 2009, Nucleic acids research.
[11] R. Steiner,et al. Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome , 2007, Journal of Inherited Metabolic Disease.
[12] A. Fischer,et al. Allogeneic bone marrow transplantation in mevalonic aciduria. , 2007, The New England journal of medicine.
[13] H. Waterham,et al. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. , 2002, Human molecular genetics.
[14] H. Waterham,et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. , 2002, Arthritis and rheumatism.
[15] H. Waterham,et al. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. , 2001, Rheumatology.
[16] H. Waterham,et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.
[17] M. Daha,et al. Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.
[18] J. Meer,et al. Interferon‐γ and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome , 1995, European journal of clinical investigation.